
Reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practice
Author(s) -
Llibre JM,
Martínez E,
Barreiro P,
Escrig R,
Ribera E,
Cervantes M,
Imaz A,
Gutierrez F,
Knobel H,
Ornelas A,
Zamora FX,
Clotet B
Publication year - 2010
Publication title -
journal of the international aids society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.724
H-Index - 62
ISSN - 1758-2652
DOI - 10.1186/1758-2652-13-s4-p35
Subject(s) - medicine , raltegravir , salvage therapy , pharmacology , protease , intensive care medicine , virology , viral load , antiretroviral therapy , human immunodeficiency virus (hiv) , chemotherapy , enzyme , biochemistry , chemistry
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK